Sovaldi ushers in wave of costly hepatitis C drugs.
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use; D005252:Fees, Pharmaceutical; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000069474:Sofosbuvir